Vitamin D deficiency and a CYP27B1–1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy - Lange, C M; Bojunga, J; Ramos-Lopez, E (J Hepatol, 2011)
et al.